Literature DB >> 33221707

Impact of nosocomial infections on patient mortality following cardiac surgery.

Olga de la Varga-Martínez1, Esther Gómez-Sánchez2, María Fe Muñoz3, Mario Lorenzo4, Estefanía Gómez-Pesquera4, Rodrigo Poves-Álvarez1, Eduardo Tamayo4, María Heredia-Rodríguez5.   

Abstract

STUDY
OBJECTIVE: To determine the rate of nosocomial infection among patients undergoing cardiac surgery and to identify risk factors and the impact of these infections on patient mortality.
DESIGN: Prospective observational study.
SETTING: Intensive Care Unit (ICU). PATIENTS: 1097 adult patients who underwent cardiac surgery at Hospital Clínico Universitario de Valladolid between January 2011 and January 2016.
INTERVENTIONS: None. MEASUREMENTS: Preoperative, intraoperative and postoperative medical, surgical and anaesthetic variables. MAIN
RESULTS: A total of 111 patients (10.1%) acquired a nosocomial infection in the postoperative period. Pneumonia was the most frequent (4.2%) nosocomial infection. Three independent risk factors for the development of a nosocomial infection were identified: cardiopulmonary bypass time, kidney failure and emergency surgery. The stay in the ICU was significantly higher in patients who developed a nosocomial infection (16.6 ± 38.8 vs. 4.4 ± 17.8, P < 0.001). The mortality rate of patients who acquired a nosocomial infection was significantly greater (18%) than that of patients who did not acquire a nosocomial infection (5%) (P < 0.001). The 90-day survival was greater in the group of patients without nosocomial infection (log rank 27.55, P < 0.001). The dynamic modelling of 90-day mortality revealed that in the first week, cardiopulmonary bypass time (HR = 1.00, 95% CI 1.00-1.02, P < 0.001) and emergency surgery (HR = 0.12, 95% CI 0.04-0.37, P < 0.001) were the most important risk factors for mortality, while after the first week, nosocomial infection (HR = 6.23, 95% CI 2.49-15.63, P < 0.001) was the main risk factor, followed by cardiopulmonary bypass time (HR = 1.01, 95% CI 1.00-1.01, P = 0.001) and EuroSCORE (HR = 1.03, 95% CI 1.00-1.06, P = 0.008).
CONCLUSIONS: Nosocomial infections after cardiac surgery constitute the main independent risk factor for mortality after the first week of surgery. These data suggest that its prevention following cardiac surgery must be prioritised to improve patient outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Mortality; Nosocomial infection; Risk factors

Mesh:

Year:  2020        PMID: 33221707     DOI: 10.1016/j.jclinane.2020.110104

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

Review 1.  Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions.

Authors:  Dashuai Wang; Yang Lu; Manda Sun; Xiaofan Huang; Xinling Du; Zhouyang Jiao; Fuqiang Sun; Fei Xie
Journal:  Front Cardiovasc Med       Date:  2022-06-30

2.  Survival rate in patients with ICU-acquired infections and its related factors in Iran's hospitals.

Authors:  MEDSKorosh Etemad; Yousef Khani; Seyed-Saeed Hashemi-Nazari; Neda Izadi; Babak Eshrati; Yadollah Mehrabi
Journal:  BMC Public Health       Date:  2021-04-24       Impact factor: 3.295

3.  Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients.

Authors:  Aimin Jiang; Xin Shi; Haoran Zheng; Na Liu; Shu Chen; Huan Gao; Mengdi Ren; Xiaoqiang Zheng; Xiao Fu; Xuan Liang; Zhiping Ruan; Tao Tian; Yu Yao
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-07       Impact factor: 4.887

4.  Establishment and Validation of a Nomogram to Predict Hospital-Acquired Infection in Elderly Patients After Cardiac Surgery.

Authors:  Yuchen Gao; Chunrong Wang; Yuefu Wang; Jun Li; Jianhui Wang; Sudena Wang; Yu Tian; Jia Liu; Xiaolin Diao; Wei Zhao
Journal:  Clin Interv Aging       Date:  2022-02-09       Impact factor: 4.458

Review 5.  Nosocomial Extracardiac Infections After Cardiac Surgery.

Authors:  Enrico Maria Zardi; Massimo Chello; Domenico Maria Zardi; Raffaele Barbato; Omar Giacinto; Ciro Mastoianni; Mario Lusini
Journal:  Curr Infect Dis Rep       Date:  2022-09-24       Impact factor: 3.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.